Sunaxa Pharma Private Limited - Company Profile

It is a business services private limited company based in Rangareddy, Telangana, India, established in 2025.
2025 Rangareddy, Telangana, India Active
Last Updated:
Access Report
About Sunaxa Pharma Private Limited

Sunaxa Pharma Private Limited, a active private limited company, was established on 29 September 2025 in Rangareddy, Telangana, India. it holds CIN: U21001TS2025PTC204580. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.50 Cr and a paid-up capital of ₹0.53 M.

Formerly known as Sunaxa Pharma Private Limited. Its leadership includes Veerareddy Vallapureddy (Director), Manasa Reddy Devireddy (Director). It holds ₹1.65 Cr open charges and no settled loans. It is based at Plot No. 10/R, S No. 37, 5-9-262/P, 3Rd Floor, Rajiv Gandhi Nagar, Prashanthi Nagar, Rangareddy, Telangana, 500037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001TS2025PTC204580

  • Registration Number

    204580

  • Incorporation Date

    29 September 2025

  • Authorized Capital

    ₹9.50 Cr

  • Paid-Up Capital

    ₹0.53 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.50 Cr
  • Paid Up Capital ₹ 0.53 M
  • Company Age 6 Months 1 Day
  • Open Charges ₹ 1.65 Cr
Company report

Sunaxa Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sunaxa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sunaxa Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Veerareddy Vallapureddy Director 29 Sep 2025 Current
Manasa Reddy Devireddy Director 29 Sep 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sunaxa Pharma.
Sunaxa Pharma revenue growth over time
Sunaxa Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sunaxa Pharma?

Unlock access to Sunaxa Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹16,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Icici Bank Limited : 1.65 Cr
Latest Charge Details
Date Lender Amount Status
29 Nov 2021 Icici Bank Limited ₹1.65 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sunaxa Pharma?

Unlock and access historical data on people associated with Sunaxa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sunaxa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunaxa Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sunaxa Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Veerareddy Vallapureddy was appointed as a Director was appointed as a Director on 29 Sep 2025 & has been associated with this company since 6 months 1 day . was documented.

  • Director Appointment

    The activity Manasa Reddy Devireddy was appointed as a Director was appointed as a Director on 29 Sep 2025 & has been associated with this company since 6 months 1 day . was completed.

  • Charges

    The activity A charge with Icici Bank Limited of Rs. 1.65 Cr registered on 29 Nov 2021 with Charge ID 100514000 was modified on 27 Sep 2022. was completed.

  • Charges

    Progress on A charge with Icici Bank Limited amounted to Rs. 1.65 Cr with Charge ID 100514000 was registered on 29 Nov 2021. was documented.

  • Company Incorporation

    The activity Sunaxa Pharma Private Limited was registered on 29 Sep 2025 with Roc Hyderabad & aged 6 months 1 day as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sunaxa Pharma Private Limited?

The CIN of Sunaxa Pharma Private Limited is U21001TS2025PTC204580.

Where is Sunaxa Pharma Private Limited headquartered?

Sunaxa Pharma Private Limited is headquartered at Plot No. 10/R, S No. 37, 5-9-262/P, 3Rd Floor, Rajiv Gandhi Nagar, Prashanthi Nagar, Rangareddy, Telangana, 500037.

When was Sunaxa Pharma Private Limited incorporated?

Sunaxa Pharma Private Limited was incorporated on 29 September 2025.

Who are the current directors of Sunaxa Pharma Private Limited?

The current directors of Sunaxa Pharma Private Limited are

Is Sunaxa Pharma Private Limited a listed company?

Sunaxa Pharma Private Limited is unlisted.

What is the capital structure of Sunaxa Pharma Private Limited?

The authorized capital of Sunaxa Pharma Private Limited is ₹9.50 Cr, and the paid-up capital is ₹0.53 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available